Chittagong Medical College
Clinical trials sponsored by Chittagong Medical College, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New heart failure drug trial aims to ease breathing and save lives Results expected Oct 2026 (estimated)
- New drug could scratch the itch for dialysis patients Results expected Jan 2027 (estimated)
- Could two old drugs beat one for migraine prevention? Results expected Mar 2027 (estimated)
- Kidney hope: two-pill combo may slow damage in diabetic patients Results expected May 2027 (estimated)
- Dialysis drug showdown: which vitamin d works best? Results expected May 2027 (estimated)
-
Three-Drug antifungal cocktails put to the test against stubborn skin fungus
Disease control CompletedDermatophytosis, a common fungal skin infection, often becomes chronic and resists standard treatment. Researchers are comparing three oral antifungal combinations: terbinafine plus fluconazole, terbinafine plus itraconazole, and terbinafine plus voriconazole. The trial enrolls 1…
Sponsor: Chittagong Medical College • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can a common arthritis drug tame the painful Flare-Ups of leprosy?
Disease control CompletedThis trial tests whether adding methotrexate to the standard steroid prednisolone better controls erythema nodosum leprosum (ENL), a painful and often recurring complication of leprosy. Adults aged 18 to 65 with active ENL will receive either prednisolone alone or prednisolone pl…
Phase 1 • Sponsor: Chittagong Medical College • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC